Nuclear EGFR has been identified in various tumor tissues, including breast cancer, ovarian cancer, and oropharyngeal and esophageal squamous cell carcinomas, and has been shown to be associated with poor patient outcomes [40]. The gene discussed is EGFR; the disease is ovarian carcinoma.